Medical News

RSS

Caregiving is a major public health issue in the U.S, says expert

The demand for at-home caregiving will increase dramatically in the United States in the years ahead, said Richard Schulz, Ph.D., an internationally known expert on caregiving from the University of Pittsburgh.

22 Oct 2009

LIVALO statin effective than simvastatin in reducing lipid levels

New Phase III data published today in "Current Medical Research and Opinion" highlight that the recommended starting dose of 2 mg of LIVALO (pitavastatin), a novel synthetic statin, was statistically superior to simvastatin at a dose of 20 mg over 12 weeks in reducing low-density lipoprotein cholesterol

22 Oct 2009

Third-quarter fiscal 2009 results announced by Life Time Fitness

Life Time Fitness, Inc. today reported its operating results for the third quarter ended September 30, 2009.

22 Oct 2009

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

Accredo Health Group Inc. announced a 10-year renewal of its 240,000-square-foot headquarters at Century Center, positioning the nation's largest specialty pharmacy and a major fixture of Memphis' health care industry for future growth. The General Investment & Development Companies and Accredo agreed to renew all leases for Accredo's five-building campus, effective January 1, 2010.

22 Oct 2009

KemPharm commences KP106 Phase 1 clinical trial for ADHD

KemPharm, Inc. today announced that it has commenced a Phase 1 clinical trial in healthy volunteers of its novel prodrug compound, KP106, which is in development for the treatment of attention-deficit hyperactivity disorder (ADHD). KP106, a new chemical entity (NCE) composed of d-amphetamine and a ligand, is the lead investigational candidate from KemPharm’s proprietary ligand activated therapy (LAT) platform, which creates improved versions of FDA-approved drugs. KemPharm began the KP106 program in 2007 and has initiated the Phase 1 clinical trial of this candidate in less than 24 months.

22 Oct 2009

BioCube completes initial phase development of environmentally safe decontamination system

Spring Creek Capital Corporation (OTCBB: SCRK), a Nevada corporation, announced today that one of its portfolio companies, BioCube, Inc., has completed the initial phase of the development of an environmentally safe decontamination system, utilizing an aerosol-based delivery method of aqueous solution.

22 Oct 2009

The E3 Advantage educational healthcare webcast series to be sponsored by MEBS

MEBS, a leading provider of employee benefit services announced its sponsorship of the healthcare webcast series, “The E3 Advantage.” The next webcast will be on November 4th at 2 p.m. ET with the topic, “Looking into the Future of Healthcare” including “The Future of Pharmacy” presented by CVS Caremark. To attend, register at www.mebs.com.

22 Oct 2009

FMWC partners with SOGC and SCC to launch Pap test campaign

The Federation of Medical Women of Canada (FMWC) has joined forces with the Society of Obstetricians and Gynaecologists of Canada (SOGC) and the Society of Canadian Colposcopists (SCC) to launch this year's Pap test campaign during Cervical Cancer Awareness Week. Together, we hope to increase the scope, reach and impact of the campaign. With this collaborative effort, we aim to provide more Pap tests and deal with abnormal results in a more expeditious manner.

22 Oct 2009

Free webinar to help people with written expression deficits

Two experts who specialize in empowering families and professionals with the knowledge of affordable technologies to maximize success are offering a free webinar about resources to support people who have written expression deficits.

22 Oct 2009

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

Applied Biosystems, part of Life Technologies Corporation, today announced the global commercial availability of a new capillary electrophoresis (CE) sequencing system. The 3500 Series Genetic Analyzer builds on Applied Biosystems’ industry-leading CE sequencing systems, with state-of-the-art advancements, setting significant new standards for throughput, data quality and ease of use.

22 Oct 2009

AdvancedMD Software in Inc. 5000 list of America's fastest growing, privately-held companies

AdvancedMD® Software, Inc., a leader in web-based practice management, billing and EMR applications for medical practices and medical billing services, today announced that for the third consecutive year the company has been named to the prestigious Inc. 5000 list of America's fastest growing, privately-held companies.

22 Oct 2009

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

The Advanced Wound Management Division of Smith & Nephew, Inc., a subsidiary of Smith & Nephew Plc (LSE: SN; NYSE: SNN), announced today that clinicians will present a total of 20 clinical posters featuring its Negative Pressure Wound Therapy (NPWT) Systems and ALLEVYN(TM) AG, ALLEVYN AG Gentle, ACTICOAT(TM) and IODOSORB(TM) advanced wound dressings during the 24th Annual Clinical Symposium on Advances in Skin and Wound Care's poster session. The poster session opens at 10:30am CT on October 23, 2009.

22 Oct 2009

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, today announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension.

22 Oct 2009

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, Ltd., a leading developer of microRNA-based molecular diagnostics, and Genetic Technologies Limited (GTG), the leading private genetic testing laboratory in Australia, announced today the signing of an exclusive distribution agreement for Rosetta Genomics’ three currently available diagnostic tests.

22 Oct 2009

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company’s RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.

22 Oct 2009

Progenika to provide blood group genotyping reference laboratory services to ARUP

Progenika, Inc. today announced that it has entered into an agreement with ARUP Laboratories (ARUP) of Salt Lake City, UT, to provide blood group genotyping reference laboratory services to ARUP to determine patient red blood cell antigen profiles when serology has logistic and functional limitations.

22 Oct 2009

Merge Healthcare's strategy to expand in China, to take part in China International Medical Equipment Fair

As a part of its ongoing strategic objective of expansion in China, Merge Healthcare (NASDAQ: MRGE) will be exhibiting at the China International Medical Equipment Fair, which will be held at the Chengdu Century City New International Convention & Exhibition Center, October 28 - 31, 2009.

22 Oct 2009

Medical News

Caregiving is a major public health issue in the U.S, says expert

LIVALO statin effective than simvastatin in reducing lipid levels

Third-quarter fiscal 2009 results announced by Life Time Fitness

Accredo Health Group announces a 10-year renewal of its headquarters with Memphis

KemPharm commences KP106 Phase 1 clinical trial for ADHD

BioCube completes initial phase development of environmentally safe decontamination system

The E3 Advantage educational healthcare webcast series to be sponsored by MEBS

FMWC partners with SOGC and SCC to launch Pap test campaign

Free webinar to help people with written expression deficits

Applied Biosystems announces the global availability of its 3500 Series Genetic Analyzer

AdvancedMD Software in Inc. 5000 list of America's fastest growing, privately-held companies

Smith & Nephew to present comprehensive portfolio of advanced wound management products at Annual Clinical Symposium

Positive results from Aerie Pharmaceuticals’ Phase 2a study of its Rho-kinase inhibitor

Rosetta Genomics, GTG sign exclusive distribution agreement

FDA grants Response Biomedical a Special 510(k) clearance for the RAMP Influenza A/B Assay

Progenika to provide blood group genotyping reference laboratory services to ARUP

Merge Healthcare's strategy to expand in China, to take part in China International Medical Equipment Fair

Antiviral prescriptions at retail pharmacies increase by 36% in one week

Mead Johnson announces its financial results for the third quarter ended Sept. 30, 2009

First-quarter fiscal 2010 results announced by Kensey Nash

Squid™ Full Range Pipette: Reduce pipette changes, bench clutter, and calibration burden

Advancing Menopause Care: Non-Hormonal Treatments for Vasomotor Symptoms

Building quality into drug development for safer, faster medicines

Latest News